[Bone pseudoprogression due to renal neoplasia during treatment with immune checkpoint inhibitors]

Medicina (B Aires). 2022;82(6):997.

[Article in Spanish]

Authors

Darío A Rueda¹, Ailén Martiarena², Carlos Bas², Gabriela Gatica²

Affiliations

¹ Instituto de Oncología, Hospital Alemán, Buenos Aires, Argentina. E-mail: darioalvarorueda@gmail.com.
² Instituto de Oncología, Hospital Alemán, Buenos Aires, Argentina.

PMID: 36571556

No abstract available

MeSH terms

Disease Progression
Humans
Immune Checkpoint Inhibitors*
Kidney Neoplasms* / diagnostic imaging
Kidney Neoplasms* / drug therapy
Nivolumab / adverse effects

Substances

Immune Checkpoint Inhibitors
Nivolumab